Vaccine News and Research

Latest Vaccine News and Research

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

The National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa.

11 Jul 2017

First vaccine protecting against gonorrhea provides opportunity for vaccine development

A meningococcal group B vaccine has been found to offer protection against gonorrhea, report researchers. This is the first time a vaccine has protected against the STD and it could open up a new pathway for vaccine development.

11 Jul 2017

Research highlights need for vaccines to prevent child deaths from fatal lung infections

Vaccines to combat a virus that can lead to fatal lung infections are urgently needed to help prevent child deaths worldwide, research suggests.

10 Jul 2017

Rise in antibiotic-resistant gonorrhea, WHO report reveals

Reports from WHO, based on the data collected from 77 countries, reveals that antibiotic resistance of gonorrhea, a common sexually transmitted infection is making the disease much harder and at times impossible to treat.

7 Jul 2017

Novel vaccine approach appears to protect fetus from CMV infection, animal study shows

Long before the Zika virus became a global fear, cytomegalovirus, or CMV, was commonly infecting developing fetuses and causing many of the same brain and developmental impairments.

6 Jul 2017

Scientists develop novel DNA-based strategy to protect against broad array of influenza viruses

A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.

6 Jul 2017

Zika: costs of prevention and control

They undertook a modelling study based on six states in the US in areas that are at risk of Zika emergence. The main finding of this study was that the total cost of Zika in these sates had a range that went from approximately 183.4 million dollars to 1.2 billion dollars.

6 Jul 2017

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

5 Jul 2017

Scientists discover role of skin in spreading leishmaniasis

Scientists at the University of York have discovered that parasites responsible for leishmaniasis - a globally occurring neglected tropical disease spread by sand flies - are mainly acquired from the skin rather than a person's blood.

5 Jul 2017

Combination treatment could be more effective against common infection

The common and highly resistant Pseudomonas aeruginosa bacterium is a fatal threat to weakened and ill patients.

4 Jul 2017

Scientists find new clues to how RSV causes disease

By age 2, most children have been infected with respiratory syncytial virus (RSV), which usually causes only mild cold symptoms. But people with weakened immune systems, such as infants and the elderly, can face serious complications, including pneumonia and -- in some cases -- death.

30 Jun 2017

Antibiotics found to be effective for treating simple skin abscesses in adults and children

New multicenter research, which included Vanderbilt University Medical Center investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph) bacteria.

30 Jun 2017

Study develops dissolvable microneedle patches for administering influenza vaccine

Study findings published online in The Lancet on June 27, 2017 have found that an experimental patch of dissolving microneedles can produce robust immune responses for influenza. The microneedle patches can be administered safely and can be a substitute for the needle-and-syringe vaccination. With further advancements, they could remove the uneasiness in using an injection and inconvenience of visiting a flu clinic, as well as offering cost benefits.

28 Jun 2017

Bandage-strip sized microneedle patches can transform flu vaccination method

A National Institutes of Health-funded study led by a team at the Georgia Institute of Technology and Emory University has shown that an influenza vaccine can produce robust immune responses and be administered safely with an experimental patch of dissolving microneedles.

28 Jun 2017

Researchers identify new therapy target for gonorrhea

Researchers have identified a possible new treatment for gonorrhea, using a peptide that thwarts the infection-causing bacterium by interfering with an enzyme the microbe needs to respirate.

27 Jun 2017

Researchers uncover three-dimensional structure of tetanus toxin protein

"Our discovery could be used to design new medicines", says Pål Stenmark, Associate Professor at the Department of Biochemistry and Biophysics, Stockholm University.

27 Jun 2017

New approaches to early detection of Parkinson's disease on the horizon

Detecting Parkinson's disease before non-reversible symptoms occur: New approaches to early detection are meant to ensure just that. They are based on detection of alpha-synuclein in the skin or intestines.

24 Jun 2017

UTEP researchers move one step closer to developing first-ever Chagas disease vaccine

A pair of scientists at The University of Texas at El Paso is one step closer to developing the first ever clinical Chagas disease vaccine.

22 Jun 2017

Scientists resolve 3D protein structures to combat dangerous infectious diseases

An international team of scientists including the Computation Institute has determined the 3-D atomic structures of more than 1,000 proteins that are potential targets for drugs and vaccines to combat some of the world's most dangerous emerging and re-emerging infectious diseases.

22 Jun 2017

Vaccines can be blamed for any illness even with lack of evidence says EU court

In a landmark judgment yesterday, the Court of Justice of the European Union ruled that courts could consider vaccines to be the reason for an illness despite the absence of any concrete evidence to support the connection.

21 Jun 2017

Vaccine News and Research

Latest Vaccine News and Research

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

First vaccine protecting against gonorrhea provides opportunity for vaccine development

Research highlights need for vaccines to prevent child deaths from fatal lung infections

Rise in antibiotic-resistant gonorrhea, WHO report reveals

Novel vaccine approach appears to protect fetus from CMV infection, animal study shows

Scientists develop novel DNA-based strategy to protect against broad array of influenza viruses

Zika: costs of prevention and control

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

Scientists discover role of skin in spreading leishmaniasis

Combination treatment could be more effective against common infection

Scientists find new clues to how RSV causes disease

Antibiotics found to be effective for treating simple skin abscesses in adults and children

Study develops dissolvable microneedle patches for administering influenza vaccine

Bandage-strip sized microneedle patches can transform flu vaccination method

Researchers identify new therapy target for gonorrhea

Researchers uncover three-dimensional structure of tetanus toxin protein

New approaches to early detection of Parkinson's disease on the horizon

UTEP researchers move one step closer to developing first-ever Chagas disease vaccine

Scientists resolve 3D protein structures to combat dangerous infectious diseases

Vaccines can be blamed for any illness even with lack of evidence says EU court

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in